Increasing geriatric population is expected to drive the growth of global cellular health screening in the forecast period, 2024-2028.
According to TechSci Research report, “Cellular Health Screening Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global cellular health screening market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing significance of healthy life expectancy and growing concerns from the government towards preventive healthcare across the globe. Additionally, rising geriatric population and increasing research and development projects for different pre-clinical studies can demand for cellular screening and the growing number of campaigns to educate the public about the signs of chronic diseases and how to prevent them in order to contain diseases epidemics, especially in the developed countries in North America and Europe is expected to create lucrative opportunities for the market growth in coming years. Besides, increasing adoption of telomere performance programs for leading a healthy life is further expected to support market growth. Similarly, growing awareness campaigns by different organizations across the globe have played a significant role in increasing the demand for testing based preventive healthcare products and service which will propel the market growth during the forecasted period.
However, rising problem associated with sample’s transportation and the lack of reimbursement policies, can create affordability issues, thereby slowing down the growth of global cellular health screening market in the forecast period. Similarly, difference in the cost kit offered by different organizations may hamper the cellular health screening market growth during the forecast period. Also, lack of awareness about new technology and instability of kits and fragility of samples, making the results less sensitive and less efficient, can further restrict the growth of global cellular health screening market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Cellular Health Screening Market“
The global cellular health screening market can be segmented by test type, by sample, by site of collection and by region. Based on test type, the global cellular health screening market can be divided into Single Test Panels and Multi Test Panels. The multi test panels segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to the increasing research about showing the correlation of telomere length on multiple molecular and cellular functions, along with the launch of new testing devices for the detection of telomere length growth. Also, growing demand for the screening of biomarkers during a single run is expected to demand for cellular health screening market during the forecasted year.
Based on site of collection, the market can be segmented into Home, Hospitals & Clinics, Diagnostic Laboratories, Others. The home segment is expected to dominate during the forecast period on account of the increasing awareness regarding health and self-sampling adoption in major markets. Similarly, the presence of a sample collection site and skilled professionals is also a major factor that will drive the market growth over the years.
Major companies operating in global cellular health screening market are:
- Telomere Diagnostics, Inc.
- Quest Diagnostics, Inc.
- Laboratory Corporation of America Holdings
- SpectraCell Laboratories, Inc.
- Cell Science Systems Corporation
- Immundiagnostik AG
- Repeat Diagnostics, Inc.
- OPKO Health, Inc.
- Genova Diagnostics, Inc.
- Titanovo, Inc.
For instance, as per the article published by theguardian.com, in February 2022, an awareness campaign has been launched in England to increase life-saving screening. This campaign was launched by the Department of Health and Social Care.
For instance, in September 2021, Genomic Vision launched TeloSizer to boost the use of telomere for biomarker discovery via its precise and quantitative detection.
For instance, in a research article published in July 2020, researchers from Japan proved that the presence of pteridine derivatives in urine is associated with oxidative stress and smoking.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the global cellular health screening market due to the increasing awareness on health, along with growing healthcare expenditure across the region. Furthermore, increasing funding by government organizations for preventive healthcare and increasing number of major key players are further contributing to the demand for cellular health screening. Besides, increasing adoption of new technologies and growing prevalence of infectious and chronic diseases in the population, regionally, is further expected to create lucrative opportunities for the market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Cellular Health Screening Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Test Type (Single Test Panels v/s Multi Test Panels), By Sample (Blood, Saliva, Urine, Others), By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others), By Region and Competition”, has evaluated the future growth potential of global cellular health screening market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global cellular health screening market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]m
Website: https://www.techsciresearch.com
